Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells

  • Ojima, Takamichi (Department of Pharmaceutics and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University) ;
  • Kawami, Masashi (Department of Pharmaceutics and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University) ;
  • Yumoto, Ryoko (Department of Pharmaceutics and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University) ;
  • Takano, Mikihisa (Department of Pharmaceutics and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University)
  • Received : 2020.07.14
  • Accepted : 2021.09.23
  • Published : 2021.07.15
⟨ Previous Next ⟩

Abstract

Epithelial-mesenchymal transition (EMT), a biological process through which epithelial cells transdifferentiate into mesenchymal cells, is involved in several pathological events, such as cancer progression and organ fibrosis. So far, we have found that methotrexate (MTX), an anticancer drug, induced EMT in the human A549 alveolar adenocarcinoma cell line. However, the relationship between EMT and the cytotoxicity induced by MTX remains unclear. In this study, we compared the processes of MTX-induced EMT and apoptosis in A549 cells. Q-VD-Oph, a caspase inhibitor, suppressed MTX-induced apoptosis, but not the increase in mRNA expression of α-smooth muscle actin (SMA), a representative EMT marker. In addition, SB431542, an EMT inhibitor, did not inhibit MTX-induced apoptosis. By using isolated clonal cells from wild-type A549 cells, the induction of EMT and apoptosis by MTX in each clone was analyzed, and no significant correlation was observed between the MTX-induced increase in α-SMA mRNA expression and the proportion of cells undergoing apoptosis. Furthermore, the increase in the mRNA expression of α-SMA was well correlated with cyclin-dependent kinase inhibitor 1A, a cell cycle arrest marker, but not with BCL-2 binding component 3 and Fas cell surface death receptor, which are both pro-apoptotic factors, indicating that the MTX-induced EMT may be related to cell cycle arrest, but not to apoptosis. These findings suggested that different mechanisms were involved in the MTX-induced EMT and apoptosis.

Keywords

Acknowledgement

This work was supported in part by the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JP18H02586, JP18K06749, and JP19K16447).

References

  1. Chen T, You Y, Jiang H, Wang ZZ (2017) Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol 232:3261-3272. https://doi.org/10.1002/jcp.25797
  2. Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890. https://doi.org/10.1016/j.cell.2009.11.007
  3. Salton F, Volpe MC, Confalonieri M (2019) Epithelial-mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis. Meddicina 55:83. https://doi.org/10.3390/medicina55040083
  4. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Investig 112:1776-1784. https://doi.org/10.1172/JCI20530
  5. Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20:69-84. https://doi.org/10.1038/s41580-018-0080-4
  6. Connolly EC, Freimuth J, Akhurst RJ (2012) Complexities of TGF-β targeted cancer therapy. Int J Biol Sci 8:964-978. https://doi.org/10.7150/ijbs.4564
  7. Chen KJ, Li Q, Wen CM, Duan ZX, Zhang JY, Xu C, Wang JM (2016) Bleomycin (BLM) induces epithelial-to-mesenchymal transition in cultured A549 cells via the TGF-β/Smad signaling pathway. J Cancer 7:1557-1564. https://doi.org/10.7150/jca.15566
  8. Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, Li J, Zhang Q (2017) Resveratrol reverses doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res 36:19. https://doi.org/10.1186/s13046-016-0487-8
  9. Kawami M, Harabayashi R, Miyamoto M, Harada R, Yumoto R, Takano M (2016) Methotrexate-induced epithelial-mesenchymal transition in the alveolar epithelial cell line A549. Lung 194:923-930. https://doi.org/10.1007/s00408-016-9935-7
  10. Kubo K, Azuma A, Kanazawa M et al (2013) Japanese Respiratory Society Committee for formulation of consensus statement for the diagnosis and treatment of drug-induced lung injuries, consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir Investig 51:260-277. https://doi.org/10.1016/j.resinv.2013.09.001
  11. Yamamoto A, Kawami M, Konaka T, Takenaka S, Yumoto R, Takano M (2019) Anticancer drug-induced epithelial-mesenchymal transition via p53/miR-34a axis in A549/ABCA3 cells. J Pharm Pharm Sci 22:516-524. https://doi.org/10.18433/jpps30660
  12. Kawami M, Harada R, Ojima T, Yamagami Y, Yumoto R, Takano M (2019) Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells. Toxicology 424:152231. https://doi.org/10.1016/j.tox.2019.06.002
  13. Sung JM, Cho HJ, Yi H et al (2008) Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 371:163-167. https://doi.org/10.1016/j.bbrc.2008.04.038
  14. Kawami M, Harabayashi R, Harada R, Yamagami Y, Yumoto R, Takano M (2018) Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549. Biochem Biophys Res Commun 497:457-463. https://doi.org/10.1016/j.bbrc.2018.02.111
  15. Takano M, Naka R, Sasaki Y, Nishimoto S, Yumoto R (2016) Effect of cigarette smoke extract on P-glycoprotein function in primary cultured and newly developed alveolar epithelial cells. Drug Metab Pharmacokinet 31:417-424. https://doi.org/10.1016/j.dmpk.2016.08.006
  16. Morandi A, Taddei ML, Chiarugi P, Giannoni E (2017) Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol 7:40. https://doi.org/10.3389/fonc.2017.00040
  17. Fischer KR, Durrans A, Lee S et al (2015) Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527:472-476. https://doi.org/10.1038/nature15748
  18. Tang L (2019) Investigating heterogeneity in HeLa cells. Nat Methods 16:281. https://doi.org/10.1038/s41592-019-0375-1
  19. Ben-David U, Siranosian B, Ha G et al (2018) Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560:325-330. https://doi.org/10.1038/s41586-018-0409-3
  20. Yang Y, Pan X, Lei W, Wang J, Song J (2006) Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 25:7235-7244. https://doi.org/10.1038/sj.onc.1209712
  21. El-Deiry WS (2016) p21 (WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res 76:5189-5191. https://doi.org/10.1158/0008-5472.CAN-16-2055
  22. Abbas T, Dutta A (2009) P21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9:400-414. https://doi.org/10.1038/nrc2657
  23. Grassi ML, Palma Cde S, Thome CH, Lanfredi GP, Poersch A, Faca VM (2017) Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics 151:2-11. https://doi.org/10.1016/j.jprot.2016.06.009
  24. Li XL, Hara T, Choi Y et al (2014) A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol 34:533-550. https://doi.org/10.1128/mcb.01043-13
  25. Bachman KE, Blair BG, Brenner K et al (2004) p21WAF1/CIP1 mediates the growth response to TGF-β in human epithelial cells. Cancer Biol Ther 3:221-225. https://doi.org/10.4161/cbt.3.2.666
  26. Zhang Y, Yan W, Jung YS, Chen X (2016) PUMA cooperates with p21 to regulate mammary epithelial morphogenesis and epithelial-to-mesenchymal transition. PLoS ONE 8:e66464. https://doi.org/10.1371/journal.pone.0066464
  27. Brosh R, Assia-Alroy Y, Molchadsky A et al (2013) p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition. Cell Death Differ 20:312-320. https://doi.org/10.1038/cdd.2012.125
  28. Termen S, Tan EJ, Heldin CH, Moustakas A (2013) p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β. J Cell Physiol 228:801-813. https://doi.org/10.1002/jcp.24229
  29. Chang CJ, Chao CH, Xia W et al (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13:317-323. https://doi.org/10.1038/ncb2173
  30. Wang Z, Jiang Y, Guan D et al (2013) Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells. PLoS ONE 8:e72846. https://doi.org/10.1371/journal.pone.0072846
  31. Rahmanian N, Hosseinimehr SJ, Khalaj A (2016) The paradox role of caspase cascade in ionizing radiation therapy. J Biomed Sci 23:88. https://doi.org/10.1186/s12929-016-0306-8
  32. Hattangadi DK, DeMasters GA, Walker TD et al (2004) Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem Pharmacol 68:1699-1708. https://doi.org/10.1016/j.bcp.2004.06.033
  33. Kolesnick R (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Investig 110:3-8. https://doi.org/10.1172/JCI16127
  34. Fekry B, Esmaeilniakooshkghazi A, Krupenko SA, Krupenko NI (2016) Ceramide synthase 6 is a novel target of methotrexate mediating its antiproliferative effect in a p53-dependent manner. PLoS ONE 11:e0146618. https://doi.org/10.1371/journal.pone.0146618

Cited by

  1. CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression vol.12, 2021, https://doi.org/10.3389/fgene.2021.728200
  2. Protection against Oxidative Stress-Induced Apoptosis by Fermented Sea Tangle (Laminaria japonica Aresch) in Osteoblastic MC3T3-E1 Cells through Activation of Nrf2 Signaling Pathway vol.10, pp.11, 2021, https://doi.org/10.3390/foods10112807
  3. Mori Ramulus Suppresses Hydrogen Peroxide-Induced Oxidative Damage in Murine Myoblast C2C12 Cells through Activation of AMPK vol.22, pp.21, 2021, https://doi.org/10.3390/ijms222111729
  4. Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53 vol.11, pp.12, 2021, https://doi.org/10.3390/biom11121853